Literature DB >> 19071049

Hypoglycemia associated with bacteremic pneumococcal infections.

I-Shiow Jan1, Tzu-Hsiu Tsai, Jong-Min Chen, Jih-Shuin Jerng, Hsin-Fang Hsu, Pei-Lun Hung, Po-Ren Hsueh, Li-Na Lee.   

Abstract

OBJECTIVES: To evaluate the prevalence and associated presentations of hypoglycemia in bacteremic pneumococcal infections, and serotypes of the isolates.
METHODS: This was a retrospective study of 70 episodes of pneumococcal bacteremia that occurred in 2004 and 2005.
RESULTS: We found hypoglycemia (plasma glucose<3.05 mmol/l)) in six (8.6%) episodes. The patients were three children (mean age 3 years 1 month; range 1 year 5 months-4 years 5 months) and three adults (mean age 73.3 years; range 63-84 years). One child with asplenia and cyanotic heart disease had primary pneumococcal bacteremia. Of the other two children, one had meningitis and the other pneumonia. All the adults had cancer with previous chemotherapy and multilobar pneumonia, which progressed rapidly to respiratory failure. All patients developed their first hypoglycemic episode within two hours after presentation. The average plasma glucose during hypoglycemia was 1.78+/-0.78 mmol/l (range 0.33-2.94 mmol/l). One child and all of the adults died. Serotypes of isolates were those usually associated with severe pneumococcal infection: 6B and 19F in the children; 3, 14, and 23F in the adults. Only the asplenic child had received pneumococcal vaccine.
CONCLUSIONS: Hypoglycemia occurred in 8.6% of bacteremic pneumococcal infections and was associated with high mortality and serotypes that cause severe invasive disease. All patients suspected of having septicemia should have their glucose checked to avoid missing hypoglycemia leading to a worsening of their already poor condition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19071049     DOI: 10.1016/j.ijid.2008.08.026

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  6 in total

1.  Childhood dysglycemia: prevalence and outcome in a referral hospital.

Authors:  Emercia Sambany; Eric Pussard; Christian Rajaonarivo; Honoré Raobijaona; Hubert Barennes
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

2.  Direct effects of TNF-α on local fuel metabolism and cytokine levels in the placebo-controlled, bilaterally infused human leg: increased insulin sensitivity, increased net protein breakdown, and increased IL-6 release.

Authors:  Ermina Bach; Roni R Nielsen; Mikkel H Vendelbo; Andreas B Møller; Niels Jessen; Mads Buhl; Thomas K-Hafstrøm; Lars Holm; Steen B Pedersen; Henriette Pilegaard; Rasmus S Biensø; Jens O L Jørgensen; Niels Møller
Journal:  Diabetes       Date:  2013-07-08       Impact factor: 9.461

3.  High Mortality Risk in Hypoglycemic and Dysglycemic Children Admitted at a Referral Hospital in a Non Malaria Tropical Setting of a Low Income Country.

Authors:  Hubert Barennes; Eng Sayavong; Eric Pussard
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

4.  Bezlotoxumab prevents extraintestinal organ damage induced by Clostridioides difficile infection.

Authors:  Steven J Mileto; Melanie L Hutton; Sarah L Walton; Antariksh Das; Lisa J Ioannidis; Don Ketagoda; Kylie M Quinn; Kate M Denton; Diana S Hansen; Dena Lyras
Journal:  Gut Microbes       Date:  2022 Jan-Dec

5.  Outer Membrane Lipoprotein Lip40 Modulates Adherence, Colonization, and Virulence of Actinobacillus pleuropneumoniae.

Authors:  Jinlin Liu; Yurou Cao; Lulu Gao; Li Zhang; Siying Gong; Jihong Yang; Haobin Zhao; Dengfu Yang; Jin Zhao; Jianzhong Meng; Qishuang Gao; Chao Qi
Journal:  Front Microbiol       Date:  2018-07-03       Impact factor: 5.640

6.  Blood Glucose Control and Opportunities for Clinical Pharmacists in Infectious Diseases Ward.

Authors:  Minoosh Shabani; Maryam Rashedi; Sareh Razzazzadeh; Ali Saffaei; Zahra Sahraei
Journal:  J Res Pharm Pract       Date:  2019-12-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.